<?xml version="1.0" encoding="UTF-8"?>
<p>We present an infant with cardiopulmonary failure secondary to unrepaired congenital heart disease exacerbated by COVID-19. Given postsurgical complications of children with viral respiratory infection,
 <sup>
  <xref rid="B13" ref-type="bibr">13</xref>
  <xref rid="B14" ref-type="bibr"/>
  <xref rid="B15" ref-type="bibr"/>
  <xref rid="B16" ref-type="bibr"/>-
  <xref rid="B17" ref-type="bibr">17</xref>
 </sup> the patient required clearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for surgical candidacy. We hypothesized that C19-CP administration may clear SARS-CoV-2 following failure of remdesivir.
</p>
